Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29865276 | 1.00 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29445810 | 0.93 | SMN1; SMN2 (0.34) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29398621 | 0.93 | SMN1; SMN2 (0.36) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL30122609 | 0.92 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29458701 | 0.92 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29475354 | 0.90 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29445819 | 0.88 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29351571 | 0.88 | CYP1A2 (0.30) | CYP2C9CYP2C19 | |
| SCHEMBL29445825 | 0.88 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29445831 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 672 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570846-B2 | Polymer composition | SYNTHOMER (UK) LIMITED (GB) | 2026-03-10 | — | — | US | claimed |
| CN-114026176-B | Molded article comprising polycarbonate resin composition | 出光兴产株式会社 | 2025-06-13 | — | — | CN | claimed |
| WO-2025099143-A1 | COMPOSITIONS FOR STABILIZING POLYMERIC MATERIALS AGAINST UV LIGHT THERMAL AND GAS FADING DEGRADATION | CYTEC INDUSTRIES INC. (US) | 2025-05-15 | — | — | WO | claimed |
| WO-2025099141-A1 | STABILIZING COMPOSITIONS FOR POLYMERIC MATERIALS | CYTEC INDUSTRIES INC. (US) | 2025-05-15 | — | — | WO | claimed |
| US-20250145818-A1 | POLYMER COMPOSITION | SYNTHOMER (UK) LIMITED (GB) | 2025-05-08 | — | — | US | claimed |
| CN-119823547-A | Biodegradable composition with low tape casting precipitation and preparation method and application thereof | 金发科技股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119684795-A | Heat aging-resistant color-changing polyphenylene sulfide material and preparation method thereof | 东莞市奥能工程塑料有限公司 | 2025-03-25 | — | — | CN | claimed |
| WO-2025056330-A1 | STABILIZED POLYMER COMPOSITIONS WITH IMPROVED COLOR RESISTANCE | CYTEC INDUSTRIES INC. (US) | 2025-03-20 | — | — | WO | claimed |
| EP-4482670-A1 | POLYMER COMPOSITION | Synthomer (UK) Limited (GB) | 2025-01-01 | — | — | EP | claimed |
| EP-3137540-B1 | STABILIZING COMPOSITIONS FOR STABILIZING MATERIALS AGAINST ULTRAVIOLET LIGHT AND THERMAL DEGRADATION | CYTEC IND INC (US) | 2024-10-30 | — | — | EP | claimed |
| CN-111607837-B | Recycled polyester fiber | 南亚塑胶工业股份有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115304912-A | Polyamide composite material and preparation method and application thereof | 江苏金发科技新材料有限公司 | 2022-11-08 | — | — | CN | claimed |
| US-11485853-B2 | Polycarbonate composition comprising pearlescent pigment and/or interference pigment | COVESTRO DEUTSCHLAND AG (DE) | 2022-11-01 | — | — | US | claimed |
| EP-2864310-B1 | STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE | CYTEC TECH CORP (US) | 2022-10-26 | — | — | EP | claimed |
| CN-115135721-A | Polycarbonate resin composition and molded article | 出光兴产株式会社 | 2022-09-30 | — | — | CN | claimed |
| US-20220212375-A1 | POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING | CYTEC TECHNOLOGY CORP. | 2022-07-07 | — | — | US | claimed |
| WO-2022131878-A1 | POLYOLEFIN POROUS SUBSTRATE CONTAINING CROSSLINKED STRUCTURE, METHOD FOR PREPARING SAME, AND CROSSLINKED-STRUCTURE-CONTAINING SEPARATOR FOR LITHIUM SECONDARY BATTERY COMPRISING SAME | 주식회사 엘지화학 | 2022-06-23 | — | — | WO | claimed |
| US-20220153959-A1 | POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM | CYTEC TECHNOLOGY CORP. | 2022-05-19 | — | — | US | claimed |
| CN-110461943-B | Polycarbonate resin composition and molded article | 出光兴产株式会社 | 2022-03-29 | — | — | CN | claimed |
| CN-110461944-B | Polycarbonate resin composition and molded article | 出光兴产株式会社 | 2022-03-29 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220212375-A1 | POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING | RPS7, MRPS27, F7 | SMN1; SMN2 3257/4885ALDH1A1 4376/4885CA2 734/4885 |
| US-20220153959-A1 | POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM | NOTUM, PMM2, WASF2 | SMN1; SMN2 1802/4885ALDH1A1 4580/4885CA2 112/4885 |
| US-12570846-B2 | Polymer composition | TTPA, PHOSPHO1, PCTP | SMN1; SMN2 2196/4885ALDH1A1 1505/4885CA2 2556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.